Cite
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps.
MLA
De Corso, Eugenio, et al. “Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-Driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps.” Current Allergy & Asthma Reports, vol. 25, no. 1, Jan. 2025, pp. 1–27. EBSCOhost, https://doi.org/10.1007/s11882-024-01186-2.
APA
De Corso, E., Hellings, P. W., Fokkens, W. J., Klimek, L., Peters, A. T., Scadding, G. K., Desrosiers, M., Lee, S. E., & Mullol, J. (2025). Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps. Current Allergy & Asthma Reports, 25(1), 1–27. https://doi.org/10.1007/s11882-024-01186-2
Chicago
De Corso, Eugenio, Peter W. Hellings, Wytske J. Fokkens, Ludger Klimek, Anju T. Peters, Glenis K. Scadding, Martin Desrosiers, Stella E. Lee, and Joaquim Mullol. 2025. “Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-Driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps.” Current Allergy & Asthma Reports 25 (1): 1–27. doi:10.1007/s11882-024-01186-2.